Table 3.

Analysis of DC-associated gene expression at different maturation stages for each DC subset

Gene no.NameRatio of DC and BMT
Mo DCsCD1a+DCsCD11cDCsCD14+DCs
Day 7Day 9Day 8Day 18Day 0Day 5Day 8Day 18
S100B 1.4 0.9 1.9 28.6 0.7 0.9 0.9 5.6 
MMP12 0.6 0.7 0.4 4.9 0.5 0.7 0.5 0.3 
TARC 2.0 20.0 0.7 24.0 0.6 0.9 0.7 0.8 
MYPT1 0.6 1.0 0.6 2.0 0.4 0.4 1.0 4.9 
CD1B 1.5 2.4 1.4 17.6 0.8 0.9 0.7 1.5 
CD20-like 1.9 0.8 6.3 18.0 1.7 0.6 6.2 20.7 
Ig superfamily Z39Ig 0.4 0.9 0.3 2.9 0.6 0.8 0.5 16.4 
HLA-DQα 1.2 3.2 0.8 9.6 0.5 0.5 1.0 2.0 
10 GPNMB 0.4 1.7 0.7 1.2 0.8 0.7 1.0 5.0 
11 Eta-1 0.8 3.2 0.4 6.3 0.5 0.5 0.7 11.8 
12 FLAP 2.7 0.9 6.8 8.1 3.0 4.9 7.0 5.4 
13 MRC1 0.9 1.6 2.1 3.8 0.7 1.0 1.2 6.1 
15 MCP4 1.1 2.9 0.3 4.5 0.4 0.6 1.2 5.6 
16 HLA-DRα 2.6 2.2 3.5 3.8 2.4 3.3 3.9 1.3 
17 HLA-DRβ 1.4 0.7 1.8 2.7 1.2 0.7 1.2 1.4 
18 RNase1 0.3 1.6 0.3 1.1 0.4 0.5 0.5 11.5 
19 DRP-2 0.9 8.9 6.4 2.4 5.9 5.7 7.9 1.1 
22 Lysosomal acid lipase 3.4 4.2 0.3 8.1 0.3 0.4 0.5 6.1 
23 Cystatin A 0.5 0.8 0.3 17.4 0.3 0.4 0.4 4.3 
24 CD36 0.4 0.8 0.8 2.9 0.8 0.8 0.9 1.2 
26 MCP1 0.3 0.7 0.2 0.5 0.2 0.3 3.3 9.6 
28 TGFBI 1.8 1.8 0.5 3.4 1.5 0.9 0.7 9.2 
30 Calmodulin 0.8 5.1 0.5 1.8 0.4 0.7 0.6 1.6 
31 MDL-1 0.4 1.0 0.4 1.3 0.6 0.8 0.7 1.9 
33 β-tubulin 1.1 2.8 0.4 2.8 0.3 0.3 0.6 2.7 
37 Enolase 1 0.6 3.8 0.3 1.4 0.1 0.1 0.4 1.5 
40 Thymosin β4 1.2 1.9 0.3 3.4 0.1 0.3 0.6 1.6 
41 Ferritin 1.3 3.7 0.1 1.9 0.0 0.1 0.3 5.1 
44 Annexin A2 0.4 3.1 0.1 4.8 0.1 0.1 0.3 2.2 
46 MGST2 0.6 1.0 0.6 3.5 0.5 0.4 1.1 3.5 
49 Factor XIIIa 0.3 1.0 0.4 0.7 0.5 0.7 0.8 3.0 
52 VAMP8 2.0 2.8 0.6 5.1 0.3 0.2 1.3 4.2 
54 Purinergic receptor 0.4 1.0 0.6 3.1 0.6 0.6 1.0 1.9 
55 ARHGDIB 0.1 0.2 0.1 1.0 0.1 0.1 0.3 2.0 
58 MHC-DMα 0.8 1.9 1.3 4.1 0.6 0.4 2.2 2.8 
61 DORA 1.7 0.9 0.5 4.0 0.4 0.6 0.7 1.8 
63 IRF4 0.3 7.9 10.0 2.2 9.3 0.9 5.8 0.4 
S4 DC-Lamp 0.3 7.4 1.4 6.3 0.4 0.8 0.5 0.4 
S5 E-cadherin 0.5 1.0 0.6 1.0 0.9 0.9 0.5 0.9 
S6 DEC205 (CD205) 0.4 2.9 0.3 1.6 0.8 0.6 0.5 0.7 
S7 Mannose receptor (CD206) 1.1 1.8 3.1 6.6 0.4 0.5 2.0 8.6 
S8 Langerin (CD207) 0.4 1.2 0.5 5.9 0.8 0.7 0.6 1.0 
Gene no.NameRatio of DC and BMT
Mo DCsCD1a+DCsCD11cDCsCD14+DCs
Day 7Day 9Day 8Day 18Day 0Day 5Day 8Day 18
S100B 1.4 0.9 1.9 28.6 0.7 0.9 0.9 5.6 
MMP12 0.6 0.7 0.4 4.9 0.5 0.7 0.5 0.3 
TARC 2.0 20.0 0.7 24.0 0.6 0.9 0.7 0.8 
MYPT1 0.6 1.0 0.6 2.0 0.4 0.4 1.0 4.9 
CD1B 1.5 2.4 1.4 17.6 0.8 0.9 0.7 1.5 
CD20-like 1.9 0.8 6.3 18.0 1.7 0.6 6.2 20.7 
Ig superfamily Z39Ig 0.4 0.9 0.3 2.9 0.6 0.8 0.5 16.4 
HLA-DQα 1.2 3.2 0.8 9.6 0.5 0.5 1.0 2.0 
10 GPNMB 0.4 1.7 0.7 1.2 0.8 0.7 1.0 5.0 
11 Eta-1 0.8 3.2 0.4 6.3 0.5 0.5 0.7 11.8 
12 FLAP 2.7 0.9 6.8 8.1 3.0 4.9 7.0 5.4 
13 MRC1 0.9 1.6 2.1 3.8 0.7 1.0 1.2 6.1 
15 MCP4 1.1 2.9 0.3 4.5 0.4 0.6 1.2 5.6 
16 HLA-DRα 2.6 2.2 3.5 3.8 2.4 3.3 3.9 1.3 
17 HLA-DRβ 1.4 0.7 1.8 2.7 1.2 0.7 1.2 1.4 
18 RNase1 0.3 1.6 0.3 1.1 0.4 0.5 0.5 11.5 
19 DRP-2 0.9 8.9 6.4 2.4 5.9 5.7 7.9 1.1 
22 Lysosomal acid lipase 3.4 4.2 0.3 8.1 0.3 0.4 0.5 6.1 
23 Cystatin A 0.5 0.8 0.3 17.4 0.3 0.4 0.4 4.3 
24 CD36 0.4 0.8 0.8 2.9 0.8 0.8 0.9 1.2 
26 MCP1 0.3 0.7 0.2 0.5 0.2 0.3 3.3 9.6 
28 TGFBI 1.8 1.8 0.5 3.4 1.5 0.9 0.7 9.2 
30 Calmodulin 0.8 5.1 0.5 1.8 0.4 0.7 0.6 1.6 
31 MDL-1 0.4 1.0 0.4 1.3 0.6 0.8 0.7 1.9 
33 β-tubulin 1.1 2.8 0.4 2.8 0.3 0.3 0.6 2.7 
37 Enolase 1 0.6 3.8 0.3 1.4 0.1 0.1 0.4 1.5 
40 Thymosin β4 1.2 1.9 0.3 3.4 0.1 0.3 0.6 1.6 
41 Ferritin 1.3 3.7 0.1 1.9 0.0 0.1 0.3 5.1 
44 Annexin A2 0.4 3.1 0.1 4.8 0.1 0.1 0.3 2.2 
46 MGST2 0.6 1.0 0.6 3.5 0.5 0.4 1.1 3.5 
49 Factor XIIIa 0.3 1.0 0.4 0.7 0.5 0.7 0.8 3.0 
52 VAMP8 2.0 2.8 0.6 5.1 0.3 0.2 1.3 4.2 
54 Purinergic receptor 0.4 1.0 0.6 3.1 0.6 0.6 1.0 1.9 
55 ARHGDIB 0.1 0.2 0.1 1.0 0.1 0.1 0.3 2.0 
58 MHC-DMα 0.8 1.9 1.3 4.1 0.6 0.4 2.2 2.8 
61 DORA 1.7 0.9 0.5 4.0 0.4 0.6 0.7 1.8 
63 IRF4 0.3 7.9 10.0 2.2 9.3 0.9 5.8 0.4 
S4 DC-Lamp 0.3 7.4 1.4 6.3 0.4 0.8 0.5 0.4 
S5 E-cadherin 0.5 1.0 0.6 1.0 0.9 0.9 0.5 0.9 
S6 DEC205 (CD205) 0.4 2.9 0.3 1.6 0.8 0.6 0.5 0.7 
S7 Mannose receptor (CD206) 1.1 1.8 3.1 6.6 0.4 0.5 2.0 8.6 
S8 Langerin (CD207) 0.4 1.2 0.5 5.9 0.8 0.7 0.6 1.0 

DC-associated genes listed in Table 1 were further analyzed at different maturation stages for each DC subset using an HI380 microarray (Creagene). Genes are listed in abbreviated form according to the number used in Tables 1 and 2. The microarray was screened with probes prepared from each DC subset (purity more than 98%) at different maturation stages and from BMTs without subtraction. The ratio of DCs to BMTs for each gene was determined from 2 different sets of experiments after background subtraction and normalization. Genes showing little difference between their mature and immature stages were omitted from the list shown in Table 2.

Close Modal

or Create an Account

Close Modal
Close Modal